Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides

摘要

Isolated polypeptides useful in ameliorating GAD-associated autoimmune disease as well as diagnostic and therapeutic methods of using the peptides are disclosed. Monoclonal antibodies specific for GAD peptides and hybridoma cells producing such are also disclosed.